Arboretum Ventures
Description
Arboretum Ventures, established in 2002 and headquartered in Ann Arbor, Michigan, is a dedicated venture capital firm with a singular focus on the healthcare sector. The firm primarily targets companies developing innovative medical technologies and healthcare services, encompassing areas such as medical devices, diagnostics, healthcare information technology, and tech-enabled services. Their investment philosophy centers on identifying promising early-stage and growth-stage companies that are poised to disrupt or significantly improve the healthcare landscape.
As an active investor, Arboretum Ventures typically takes a hands-on approach, often securing a board seat and collaborating closely with management teams to foster growth and strategic development. The firm has demonstrated significant financial capacity, having successfully raised over $700 million across five distinct funds since its inception. Their most recent fund, Fund V, closed in 2019 with $220 million, underscoring their continued commitment and substantial capital available for new investments.
Arboretum Ventures' typical initial investment ranges from $5 million to $15 million, reflecting their commitment to providing substantial early capital to promising ventures. While their initial checks fall within this range, they possess the capacity to invest up to $25 million over the life of a company, supporting portfolio companies through various growth stages. Their robust portfolio includes more than 60 investments, with a track record of over 15 successful exits, highlighting their ability to identify and nurture companies towards significant liquidity events within the competitive healthcare market.
Investor Profile
Arboretum Ventures has backed more than 106 startups, with 5 new investments in the last 12 months alone. The firm has led 46 rounds, about 43% of its total and boasts 24 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Led 2 rounds in the past year.
- Typical check size: $5M – $15M.
Stage Focus
- Series A (25%)
- Series B (25%)
- Series C (17%)
- Series Unknown (14%)
- Series D (10%)
- Series E (2%)
- Seed (2%)
- Series F (1%)
- Private Equity (1%)
- Series G (1%)
Country Focus
- United States (98%)
- Canada (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Pharmaceutical
- Software
- Health Diagnostics
- Manufacturing
- Hospital
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
